Olopatadina Farto (Olopatadine)

Olopatadine, the active ingredient in Olopatadina Farto, is an antihistamine presented as an ophthalmic solution for ocular use. It treats allergic inflammation of the eye, providing relief in conditions such as allergic conjunctivitis and seasonal allergic eye disease.

GNH USA supplies Olopatadina Farto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olopatadine is used to manage allergic eye conditions by blocking histamine activity and stabilising mast cells. - Allergic conjunctivitis: reduces redness, itching and watery discharge. - Seasonal allergic eye disease: alleviates symptoms triggered by pollen or other seasonal allergens. - Vernal keratoconjunctivitis: helps control chronic inflammation in severe seasonal forms.

Olopatadina Farto may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation. - Stinging upon instillation. - Transient blurred vision. - Dry eye sensation. - Headache. - Mild conjunctival hyperemia.

Serious or Rare Side Effects: - Allergic reaction including angio‑edema or anaphylaxis. - Severe eye inflammation or keratitis. - Corneal ulceration. - Increased intra‑ocular pressure. - Persistent visual disturbances. - Systemic hypersensitivity with rash or swelling.

Before using Olopatadina Farto, consider the following safety measures. - Hypersensitivity: avoid if known allergy to olopatadine or formulation components. - Glaucoma: use with caution; monitor intra‑ocular pressure. - Ocular infection: do not use in active bacterial or viral eye infections without physician guidance. - Contact lens wear: remove lenses before instillation and wait before reinserting. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Olopatadina Farto may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic antihistamines: additive sedative or anticholinergic effects. - Topical ocular anesthetics: increased risk of corneal irritation.

Moderate Interactions (Monitor Closely): - NSAID eye drops: potential for corneal toxicity. - Other mast‑cell stabilisers: may diminish therapeutic benefit. - Preservative‑containing contact lens solutions: heightened ocular irritation.